FDA Wants Stronger Warnings on Immunosuppressants

July 15th, 2009    Posted by: admin

WASHINGTON (MedPage Today) — The FDA will require some immunosuppressant drug manufacturers to update product labels to reflect increased infection risk, an FDA release said today.

Share

Leave a Reply

 

Navigation:

brought by WordPress Themes